Doug Brunk

Doug Brunk is a San Diego-based award-winning reporter who began covering health care in 1991. Before joining the company, he wrote for the health sciences division of Columbia University and was an associate editor at Contemporary Long Term Care magazine when it won a Jesse H. Neal Award. His work has been syndicated by the Los Angeles Times and he is the author of two books related to the University of Kentucky Wildcats men's basketball program. Doug has a master’s degree in magazine journalism from the S.I. Newhouse School of Public Communications at Syracuse University. Follow him on Twitter @dougbrunk.

News

Device that couples US, radiofrequency shows promise for wrinkles, skin laxity

Author:: Doug Brunk

Publish date: April 29, 2022

The new device, which is not yet available, allows for the delivery of radiofrequency and targeted ultrasound in a single applicator.

News

Synthetic, botanical agents emerging as promising melasma treatments

Author:: Doug Brunk

Publish date: April 29, 2022

“None of our patients can be on hydroquinone yearlong, so you have to bring in other agents that are efficacious,” Dr. Nada Elbuluk said.

News

NB-UVB phototherapy plays a key role in psoriasis treatment, expert says

Author:: Doug Brunk

Publish date: April 28, 2022

Home phototherapy booths provide a safe and effective way to use NB-UVB phototherapy while minimizing copays and commuting costs.

News

Which solid organ transplant recipients face the highest risk of skin cancer?

Author:: Doug Brunk

Publish date: April 27, 2022

Those at low risk for skin cancer include abdominal organ recipients, SOTR age of younger than 50 at time of transplant, and female gender.

News

Hair loss: Consider a patient’s supplement use

Author:: Doug Brunk

Publish date: April 26, 2022

Insufficient data exist to recommend supplementation with zinc, riboflavin, folic acid, or vitamin B₁₂ for hair loss, “but they may help...

News

PLA testing brings nuance to the diagnosis of early-stage melanoma

Author:: Doug Brunk

Publish date: April 11, 2022

“Future prospective randomized clinical trials are needed to examine role of genetic expression profiling in staging and managing patients,” Dr. Ca...

News

Photoprotection strategies for melasma are increasing

Author:: Doug Brunk

Publish date: April 5, 2022

A guide to tinted sunscreens published in December 2021 recommended that consumers choose a product that contains iron oxides, is labeled as broad ...

News

Global registry tracks COVID-19 outcomes in atopic dermatitis patients

Author:: Doug Brunk

Publish date: March 30, 2022

Dupilumab monotherapy was associated with lower odds of hospitalizations compared with other therapies.

News

Novel isotretinoin ointment for congenital ichthyosis shows promise

Author:: Doug Brunk

Publish date: March 27, 2022

“There is currently no FDA-approved drug for congenital ichthyosis,” Dr. Christopher G. Bunick said.

News

COVID-19 infection linked to risk of cutaneous autoimmune and vascular diseases

Author:: Doug Brunk

Publish date: March 26, 2022

“Our theory is that the severe inflammatory nature of COVID-19 leads to a lot of internal organ damage and exposure of autoantigens in that process...

News

Topical options for treating melasma continue to expand

Author:: Doug Brunk

Publish date: March 26, 2022

“We have to tell our patients that melasma therapy is a journey of skin lightening but it’s not going to be a one-stop shop of getting it completel...

News

Q&A With JAAD Editor Dirk M. Elston, MD

Author:: Doug Brunk

Publish date: March 14, 2022

“We are in a golden age of therapeutic innovations that are life changing and lifesaving for our patients,” Dr. Dirk M. Elston said.

News

Why is there an increased risk of cancer in depressed patients?

Author:: Doug Brunk

Publish date: March 9, 2022

“We have to think about depression as a systemic illness,” Dr. Charles B. Nemeroff said. “What is depression doing that’s creating a fertile enviro...